Anti-Covid vaccine starting from central Italy. Pomezia in the province of Rome is the city that brings good results. Made by a company from Pomezia, which is working hard in collaboration with the University of Oxford, the vaccine is no longer a mirage.
Anti-covid vaccine
The anti-covid vaccine to fight the #Coronavirus will be tested on five hundred and fifty volunteers from the end of April. It will therefore be a company in the province of Rome to create the coveted vaccine to stem the great contagion. Advent-Irbm, together with Oxford University's Jenner Institute, has accelerated the research work. This will be possible, thanks to the data acquired in the last settimane of continuous work. The first "pilot batch" of the vaccine will therefore leave Pomezia for England with high hopes.
It will be a question of implementing accelerated tests on healthy volunteers. It was the CEO of Irbm, Piero Di Lorenzo who declared that we are close to taking a big step. The final phase has entered the negotiation that will give a rather substantial financing, with a group of international investors; with various governments to collaborate to speed up the development of the project. Naturally, this consortium aims to encourage rapid industrial production of the vaccine.
Anti-covid and Advent-Irbm vaccine from Pomezia
Deciding to experiment on humans was possible in such a short time thanks to the non-toxicity tests and the efficacy of the product in the laboratory. Research laboratories around the world are engaged in the study, that finally brings down the coronavirus emergency. Therefore, if the Italian-British project goes well end, it is expected, to make the vaccine usable as early as September for health personnel and law enforcement agencies.
There are many forces active in the field against the epidemic. One of the hopes against the coronavirus is also a vaccine which is administered through a patch; drug they are testing in Pittsburgh. This project too has a strong Italian component, in fact, it is led by the Italian researcher Andrew Gambotto. In this regard, the results of the animal tests that have already been running for weeks, they are quite encouraging.
Andrew Gambotto
The tests in this regard are very positive, as they turned out to be similar to the results in other tests on different coronaviruses. According to Dr. Gambotto, in this relentless fight against Covid 19, the positive immune response to the vaccine is not negligible. This makes the team feel optimistic. According to the Italian scientific researcher, who lives and works in the United States, we are making great progress and fast. At a time when the emergency is waning, before moving on to human tests, we will have to consider numerous other confirmatory tests. Since the infected in the IT world; they are an exorbitant number and potentially can still infect a lot, we will certainly have to speed up the tests. Well, there are several vaccines that are being worked on around the world. All researchers try to induce immunity against the Spike protein. This thanks to the studies of the team of dr. Gambotto, dating back to the times of the Sars epidemic, as he himself claims.
Oxford University
Finally, we all have high hopes for an effective and available vaccine as soon as possible. However, the road traveled by the Advent-Irbm of Pomezia in collaboration with the Jenner Institute of Oxford University, seems to be one of the closest to the finish line. The possibility of having a vaccine as early as September would be a huge achievement. Well, the optimism of Irbm and Oxford University is more than encouraging; considering the proverbial prudence in similar matters. The non-toxicity and efficacy of the vaccine on the basis of laboratory results are one of the first "steps"; which we hope will lead to a successful resolution of the pandemic.
# Italian in the heart